GATA2 zinc finger 2 mutation found in acute myeloid leukemia impairs myeloid differentiation

Leukemia Research Reports

Volumn 2, Issue 1, 2013, Pages 21-25

  Niimi, Keiko ^a   Kiyoi, Hitoshi ^a   Ishikawa, Yuichi ^a   Hayakawa, Fumihiko ^a   Kurahashi, Shingo ^a   Kihara, Rika ^a   Tomita, Akihiro ^a   Naoe, Tomoki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

AML; Differentiation; GATA2; Mutation

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; TRANSCRIPTION FACTOR GATA 2; ZINC FINGER PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA BINDING; GENE INSERTION; GENE MUTATION; GENETIC TRANSCRIPTION; GRANULOCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMOGENESIS; MAJOR CLINICAL STUDY; MYELOID DIFFERENTIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE; ZINC FINGER MOTIF;

EID: 84878367249     PISSN: 22130489     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lrr.2013.02.002     Document Type: Article

References (11)

1. Orkin S.H. Diversification of haematopoietic stem cells to specific lineages. Nature Reviews Genetics 2000, 1:57-64.
2. Zhang S.J., Ma L.Y., Huang Q.H., Li G., Gu B.W., Gao X.D., et al. Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:2076-2081.
3. Hahn C.N., Chong C.E., Carmichael C.L., Wilkins E.J., Brautigan P.J., Li X.C., et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nature Genetics 2011, 43:1012-1017.
4. Ostergaard P., Simpson M.A., Connell F.C., Steward C.G., Brice G., Woollard W.J., et al. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nature Genetics 2011, 43:929-931.
5. Greif P.A., Dufour A., Konstandin N.P., Ksienzyk B., Zellmeier E., Tizazu B., et al. GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia. Blood 2012, 120:395-403.
6. Ozawa Y., Towatari M., Tsuzuki S., Hayakawa F., Maeda T., Miyata Y., et al. Histone deacetylase 3 associates with and represses the transcription factor GATA-2. Blood 2001, 98:2116-2123.
7. Shiotsu Y., Kiyoi H., Ishikawa Y., Tanizaki R., Shimizu M., Umehara H., et al. KW-2449, a novel multikinase inhibitor, suppresses the growth of leukemia cells with FLT3 mutations or T315I-mutated BCR/ABL translocation. Blood 2009, 114:1607-1617.
8. Hyde R.K., Liu P.P. GATA2 mutations lead to MDS and AML. Nature Genetics 2011, 43:926-927.
9. De Felice L., Tatarelli C., Mascolo M.G., Gregorj C., Agostini F., Fiorini R., et al. Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells. Cancer Research 2005, 65:1505-1513.
10. Rodriguez S., Wang L., Mumaw C., Srour E.F., Lo Celso C., Nakayama K., et al. The SKP2 E3 ligase regulates basal homeostasis and stress-induced regeneration of HSCs. Blood 2011, 117:6509-6519.
11. Zhu J., Zhou J., Peres L., Riaucoux F., Honore N., Kogan S., et al. A sumoylation site in PML/RARA is essential for leukemic transformation. Cancer Cell 2005, 7:143-153.